[Effect of the Stellamune Mycoplasma vaccine on growth, energy conversion, death, and medication use in fattening pigs on a pig farm chronically infected with Mycoplasma hyopneumoniae].
The effect of Stellamune Mycoplasma vaccine, administered to piglets aged 2-15 days and then 13-15 days later, on daily weight gain, energy conversion, and use of medication was examined in fattening pigs on a chronically Mycoplasma hyopneumoniae infected pig farm. Half of the piglets were vaccinated and the other half acted as controls. In the study design, half of the pens in the fattening unit were allocated to vaccinated pigs; the other half to non-vaccinated pigs, pen was the experimental unit. In the fattening pens sows and castrated boars were separated. The study consisted of a total of 37 pens with vaccinated, and 37 pens with non-vaccinated pigs in 12 different compartments within the pig herd. In the finishing period, mean growth performance and mean energy conversion (EV/kg) of vaccinated animals was 65 grams/day higher and 0.07 EV/kg lower than in control pigs. Furthermore, the incidence of individual curative medication against respiratory problems was more than 4 times higher in control pigs than in vaccinated pigs. There was a tendency for a higher number of group medications against respiratory problems in control pigs than in vaccinated pigs. It is concluded that, in this herd, vaccination against M. hyopneumoniae was successful from an economic point of view.
Bouwkamp
F T
FT
Afdeling varkensgezondheidszorg, Gezondheidsdienst voor Dieren, Deventer.
Elbers
A R
AR
Hunneman
W A
WA
Klaassen
C H
CH
D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000191:economics / Q000276:immunology; D004734:Energy Metabolism; D006128:Growth; D008168:Lung / Q000382:microbiology / Q000473:pathology; D009174:Mycoplasma / Q000276:immunology*; D009175:Mycoplasma Infections / Q000401:mortality / Q000517:prevention & control / Q000662:veterinary*; D011897:Random Allocation; D013552:Swine; D013553:Swine Diseases / Q000401:mortality / Q000517:prevention & control*
D001428:Bacterial Vaccines